ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1665

Multicenter Randomized Controlled Trial of Physical Therapy (PT) or Sham PT in Persons with Knee Pain, Meniscal Tear, and Osteoarthritic Imaging Changes

Jeffrey Katz1, Jamie Collins2, Leslie Bisson3, Faith Selzer4, Morgan Jones2, Heidi Yang2, James Irrgang5, Clare Safran-Norton2, Kurt Spindler6 and Elena Losina2, 1Brigham and Women's Hospital, Brookline, MA, 2Brigham and Women's Hospital, Boston, MA, 3University at Buffalo, Buffalo, NY, 4Brigham and Women's Hospital, Amesbury, MA, 5University of Pittsburgh, Pittsburgh, PA, 6Cleveland Clinic, Clev, OH

Meeting: ACR Convergence 2024

Keywords: Orthopedics, Osteoarthritis, physical therapy, Randomized Trial

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Abstracts: Orthopedics, Low Back Pain, & Rehabilitation

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: The syndrome of knee pain and meniscal tear (MT) is prevalent and disabling. The TeMPO trial (Treatment of Meniscal Problems in Osteoarthritis (OA)) compares the efficacy of in-clinic PT (true PT and sham) with a home exercise program in persons with symptomatic meniscal tear and OA.

Methods: TeMPO  is a 4-center RCT of 4 strategies: 1) Home exercises (HomeEx) focused on strengthening and stretching; 2) Home exercises + SMS messaging 3x per week to motivate adherence (HomeEx+SMS); 3) Home exercise, SMS, + PT focused on strengthening, manual therapy, and neuromuscular function (True PT)); and 4) Home exercise, SMS + sham PT consisting of ultrasound with energy turned off and light massage distant from the knee joint (Sham PT)). The sham and true PT regimens were delivered in 14 sessions over 12 weeks. The primary outcome was change in KOOS Pain between baseline and 3-months, assessed in a linear regression model adjusting for site, baseline Kellgren-Lawrence (KL) grade, and baseline KOOS Pain. A secondary outcome was treatment failure at 3 months, defined as failing to improve by 8 points in KOOS Pain, or receiving an intraarticular injection, or surgery. We assessed Pain Scores across baseline, 3, 6, and 12 months in a repeated measures model that adjusted for site and baseline KL.

Results: At baseline the 879 randomized subjects had mean age 59.2 (SD 7.8), mean BMI 29.3 (SD 6.5), 57% female, and 33% KL 3.  We obtained outcome data on 87% of subjects at 3 months and 83% at 12 months.  Baseline KOOS Pain score (0-100 with 100 worst) was 46.1 (SD 15.5).  The mean (SD) improvement in KOOS Pain at 3 months was 18.6 (SD 16.9) points in the whole cohort with no clinically important or statistically significant differences between any of the arms (Table1 and Figure 1). All subjects improved from baseline to 3 months by a mean of ~15% on strength in the quadriceps, hamstring, and gluteus medius muscles with no differences across groups. 30-36% of subjects experienced treatment failure (36% with HomeEx, 32% with HomeEx+SMS, 30% with Sham PT and 35% with True PT; p=0.58). The repeated measures analysis (Figure 2) showed that at 12 months the True PT and Sham PT groups reported greater improvement in pain (by ~5 KOOS points, 30% of a SD) than the groups that were not randomized to see a physical therapist, with no clinically important or statistically significant differences between the True PT and Sham PT groups.

Conclusion: At 3 months all treatment groups experienced clinically relevant improvement in pain and muscle strength with no clinically important or statistically significant differences in pain relief between any of the treatment arms. Electronic reminders to comply with the home exercise program did not provide discernable benefit. By12 months, subjects randomized to see a physical therapist reported greater improvement in pain scores (by 5 points) than those that did not see a therapist, with identical improvement in the sham PT and real PT groups. These findings point to delayed and sustained benefit from seeing a physical therapist and suggest the active ingredient in the PT program may have been interaction with the therapist rather than manual therapy or supervision of strengthening exercises.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: J. Katz: None; J. Collins: Boston Imaging Core Lab LLC, 2; L. Bisson: None; F. Selzer: None; M. Jones: Grunenthal, 1, Journal of Bone and Joint Surgery, 12, Online learning editor; H. Yang: None; J. Irrgang: None; C. Safran-Norton: None; K. Spindler: Oberd, 9; E. Losina: None.

To cite this abstract in AMA style:

Katz J, Collins J, Bisson L, Selzer F, Jones M, Yang H, Irrgang J, Safran-Norton C, Spindler K, Losina E. Multicenter Randomized Controlled Trial of Physical Therapy (PT) or Sham PT in Persons with Knee Pain, Meniscal Tear, and Osteoarthritic Imaging Changes [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/multicenter-randomized-controlled-trial-of-physical-therapy-pt-or-sham-pt-in-persons-with-knee-pain-meniscal-tear-and-osteoarthritic-imaging-changes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multicenter-randomized-controlled-trial-of-physical-therapy-pt-or-sham-pt-in-persons-with-knee-pain-meniscal-tear-and-osteoarthritic-imaging-changes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology